On November 14, the Food and Drug Administration (FDA) will hold a public hearing on Behind-the-Counter Availability of Certain Drugs. This webinar will present the highlights of the hearing, as well as industry, consumer health, and public policy perspectives on the current status of behind-the-counter drugs.
Explore
Membership
